Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 920618, 12 pages
http://dx.doi.org/10.1155/2015/920618
Review Article

The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms

1Department of Internal Medicine, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, Republic of Korea
2Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University, College of Human Medicine, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA

Received 24 June 2014; Revised 12 September 2014; Accepted 8 October 2014

Academic Editor: Viroj Boonyaratanakornkit

Copyright © 2015 Kyong Hye Joung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [18 citations]

The following is the list of published articles that have cited the current article.

  • Denise Soltow Hershey, “Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life.,” Asia-Pacific journal of oncology nursing, vol. 4, no. 4, pp. 313–318, . View at Publisher · View at Google Scholar
  • Brittany Lees, and Charles A. Leath, “The Impact of Diabetes on Gynecologic Cancer: Current Status and Future Directions,” Current Obstetrics and Gynecology Reports, 2015. View at Publisher · View at Google Scholar
  • Güzin Fidan-Yaylalı, Yavuz Dodurga, Mücahit Seçme, and Levent Elmas, “Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells,” Tumor Biology, 2015. View at Publisher · View at Google Scholar
  • Arthur Matyszewski, Anna M. Czarnecka, Wojciech Kukwa, Piotr Korzen, Ilan J. Safir, and Cezary Szczylik, “The role of diabetes in molecular pathogenesis of cancer,” Current Signal Transduction Therapy, vol. 10, no. 1, pp. 10–16, 2015. View at Publisher · View at Google Scholar
  • Robert Rountree, and Dwight L. McKee, “Alternative Theories of Cancer Causation - Are DNA Mutations Primary?: A Clinical Conversation,” Alternative and Complementary Therapies, vol. 21, no. 4, pp. 151–156, 2015. View at Publisher · View at Google Scholar
  • Fiorella Guadagni, Mario Roselli, Silvia Riondino, Vincenzo Formica, Jhessica Alessandroni, Roberta D’Alessandro, Augusto Orlandi, Leopoldo Costarelli, Patrizia Ferroni, Francesco Cavaliere, Anastasia Laudisi, and Ilaria Portarena, “Pretreatment insulin levels as a prognostic factor for breast cancer progression,” Oncologist, vol. 21, no. 9, pp. 1041–1049, 2016. View at Publisher · View at Google Scholar
  • Zheng Tang, Jiwei Wang, Hao Zhang, Li Sun, Furong Tang, Qinglong Deng, and Jinming Yu Yu, “Associations between diabetes and quality of life among breast cancer survivors,” PLoS ONE, vol. 11, no. 6, 2016. View at Publisher · View at Google Scholar
  • Mathias Krockenberger, Achim Wöckel, and Rolf Kreienberg, “Hohe Heilungschancen bei Brustkrebs,” MMW - Fortschritte der Medizin, vol. 158, no. 11, pp. 58–65, 2016. View at Publisher · View at Google Scholar
  • Terhi T. Piltonen, “Endometrial markers,” Best Practice & Research Clinical Obstetrics & Gynaecology, 2016. View at Publisher · View at Google Scholar
  • Luis Antonio Flores-López, María Guadalupe Martínez-Hernández, Rubí Viedma-Rodríguez, Margarita Díaz-Flores, and Luis Arturo Baiza-Gutman, “High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells,” Cellular Oncology, 2016. View at Publisher · View at Google Scholar
  • Ruth E. Patterson, Catherine R. Marinac, Loki Natarajan, Sheri J. Hartman, Lisa Cadmus-Bertram, Shirley W. Flatt, Hongying Li, Barbara Parker, Jesica Oratowski-Coleman, Adriana Villaseñor, Suneeta Godbole, and Jacqueline Kerr, “Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors,” Contemporary Clinical Trials, vol. 47, pp. 64–71, 2016. View at Publisher · View at Google Scholar
  • Ximena Gianuzzi, Gabriela Palma-Ardiles, Wendy Hernandez-Fernandez, Vinay Pasupuleti, Adrian V. Hernandez, and Faustino R. Perez-Lopez, “Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: A systematic review and meta-analysis,” Maturitas, vol. 94, pp. 22–29, 2016. View at Publisher · View at Google Scholar
  • Ingporn Jiamset, and Jitti Hanprasertpong, “Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer,” Journal of Gynecologic Oncology, vol. 27, no. 3, 2016. View at Publisher · View at Google Scholar
  • Ratika Samtani, Noopur Sharma, and Deepali Garg, “Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review,” Reproductive Sciences, pp. 193371911771126, 2017. View at Publisher · View at Google Scholar
  • Xian-Fu Sun, Ying-Bo Shao, Ming-Ge Liu, Chen, Zhao-Jun Liu, Bin Xu, Su-Xia Luo, and Hui Liu, “High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1/MMP2/MMP9 axis expression,” Oncology Letters, vol. 13, no. 5, pp. 2989–2995, 2017. View at Publisher · View at Google Scholar
  • Wenyan Tian, Fei Teng, Jing Zhao, Jinping Gao, Chao Gao, Dandan Sun, Guoyan Liu, Yanfang Zhang, Shizhu Yu, Wei Zhang, Yingmei Wang, and Fengxia Xue, “Estrogen and insulin synergistically promote type 1 endometrial cancer progression,” Cancer Biology & Therapy, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • William B. Grant, “Re: Prospective study of ultraviolet radiation exposure and risk of breast cancer in the United States,” Environmental Research, vol. 152, pp. 517–518, 2017. View at Publisher · View at Google Scholar
  • Andra-Iulia Suceveanu, Adrian-Paul Suceveanu, Andreea-Daniela Gheorghe, and Laura Mazilu, “Diabetes and Cancer: Is there a Link?,” Diabetes and Its Complications, 2018. View at Publisher · View at Google Scholar